Literature DB >> 29752276

Classification of Pancreatic Cancer: Ready for Practical Application?

Danny N Khalil1,2,3, Eileen M O'Reilly4,3,5.   

Abstract

There is great interest in an ability to categorize pancreatic cancer, and understand and classify the significant heterogeneity that exists in this disease. Such classifications based on morphologic, genetic, and immunologic features are emerging, and the application of this information to provide both prognostic and predictive information is highly desired. Clin Cancer Res; 24(18); 4355-6. ©2018 AACRSee related article by Wartenberg et al., p. 4444. ©2018 American Association for Cancer Research.

Entities:  

Mesh：

Year:  2018        PMID： 29752276      PMCID： PMC6139048          DOI： 10.1158/1078-0432.CCR-18-1113

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  5 in total

Review 1.  T cell exclusion, immune privilege, and the tumor microenvironment.

Authors:  Johanna A Joyce; Douglas T Fearon
Journal:  Science       Date:  2015-04-03       Impact factor: 47.728

2.  Genomic analyses identify molecular subtypes of pancreatic cancer.

Authors:  Peter Bailey; David K Chang; Katia Nones; Amber L Johns; Ann-Marie Patch; Marie-Claude Gingras; David K Miller; Angelika N Christ; Tim J C Bruxner; Michael C Quinn; Craig Nourse; L Charles Murtaugh; Ivon Harliwong; Senel Idrisoglu; Suzanne Manning; Ehsan Nourbakhsh; Shivangi Wani; Lynn Fink; Oliver Holmes; Venessa Chin; Matthew J Anderson; Stephen Kazakoff; Conrad Leonard; Felicity Newell; Nick Waddell; Scott Wood; Qinying Xu; Peter J Wilson; Nicole Cloonan; Karin S Kassahn; Darrin Taylor; Kelly Quek; Alan Robertson; Lorena Pantano; Laura Mincarelli; Luis N Sanchez; Lisa Evers; Jianmin Wu; Mark Pinese; Mark J Cowley; Marc D Jones; Emily K Colvin; Adnan M Nagrial; Emily S Humphrey; Lorraine A Chantrill; Amanda Mawson; Jeremy Humphris; Angela Chou; Marina Pajic; Christopher J Scarlett; Andreia V Pinho; Marc Giry-Laterriere; Ilse Rooman; Jaswinder S Samra; James G Kench; Jessica A Lovell; Neil D Merrett; Christopher W Toon; Krishna Epari; Nam Q Nguyen; Andrew Barbour; Nikolajs Zeps; Kim Moran-Jones; Nigel B Jamieson; Janet S Graham; Fraser Duthie; Karin Oien; Jane Hair; Robert Grützmann; Anirban Maitra; Christine A Iacobuzio-Donahue; Christopher L Wolfgang; Richard A Morgan; Rita T Lawlor; Vincenzo Corbo; Claudio Bassi; Borislav Rusev; Paola Capelli; Roberto Salvia; Giampaolo Tortora; Debabrata Mukhopadhyay; Gloria M Petersen; Donna M Munzy; William E Fisher; Saadia A Karim; James R Eshleman; Ralph H Hruban; Christian Pilarsky; Jennifer P Morton; Owen J Sansom; Aldo Scarpa; Elizabeth A Musgrove; Ulla-Maja Hagbo Bailey; Oliver Hofmann; Robert L Sutherland; David A Wheeler; Anthony J Gill; Richard A Gibbs; John V Pearson; Nicola Waddell; Andrew V Biankin; Sean M Grimmond
Journal:  Nature       Date:  2016-02-24       Impact factor: 49.962

3.  Integrated Genomic and Immunophenotypic Classification of Pancreatic Cancer Reveals Three Distinct Subtypes with Prognostic/Predictive Significance.

Authors:  Martin Wartenberg; Silvia Cibin; Inti Zlobec; Erik Vassella; Serenella Eppenberger-Castori; Luigi Terracciano; Micha David Eichmann; Mathias Worni; Beat Gloor; Aurel Perren; Eva Karamitopoulou
Journal:  Clin Cancer Res       Date:  2018-04-16       Impact factor: 12.531

4.  Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy.

Authors:  Eric A Collisson; Anguraj Sadanandam; Peter Olson; William J Gibb; Morgan Truitt; Shenda Gu; Janine Cooc; Jennifer Weinkle; Grace E Kim; Lakshmi Jakkula; Heidi S Feiler; Andrew H Ko; Adam B Olshen; Kathleen L Danenberg; Margaret A Tempero; Paul T Spellman; Douglas Hanahan; Joe W Gray
Journal:  Nat Med       Date:  2011-04-03       Impact factor: 53.440

5.  Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma.

Authors:  Richard A Moffitt; Raoud Marayati; Elizabeth L Flate; Keith E Volmar; S Gabriela Herrera Loeza; Katherine A Hoadley; Naim U Rashid; Lindsay A Williams; Samuel C Eaton; Alexander H Chung; Jadwiga K Smyla; Judy M Anderson; Hong Jin Kim; David J Bentrem; Mark S Talamonti; Christine A Iacobuzio-Donahue; Michael A Hollingsworth; Jen Jen Yeh
Journal:  Nat Genet       Date:  2015-09-07       Impact factor: 38.330
  5 in total
  2 in total

1.  The m6A-Related mRNA Signature Predicts the Prognosis of Pancreatic Cancer Patients.

Authors:  Zibo Meng; Qingchen Yuan; Jingyuan Zhao; Bo Wang; Shoukang Li; Rienk Offringa; Xin Jin; Heshui Wu
Journal:  Mol Ther Oncolytics       Date:  2020-04-29       Impact factor: 7.200

Review 2.  Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine.

Authors:  Yiqi Yu; Gang Yang; Hua Huang; Ziyao Fu; Zhe Cao; Lianfang Zheng; Lei You; Taiping Zhang
Journal:  J Exp Clin Cancer Res       Date:  2021-01-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.